CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

Janina Graule(University of Bern), Inti Zlobec(University of Bern)

Clinical Epigenetics

September 26, 2018

10.1186/s13148-018-0548-2

Cited by 88

Related Papers

Clinicopathological and protein characterization of <i>BRAF</i>‐ and <i>K‐RAS</i>‐mutated colorectal cancer and implications for prognosis

|International Journal of Cancer|2010|172

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer

|PLoS ONE|2010|58

A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer

|Research Square|2022|0